Latest News about GILD
Recent news which mentions GILD
Gilead Sciences Battles Rising Threat of Drug Counterfeiting, Initiates Legal Actions
December 11, 2023
From Benzinga
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
December 10, 2023
From Motley Fool
Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy
December 07, 2023
From InvestorPlace
3 Biotech Stocks That Could Be Multibaggers in the Making
November 30, 2023
From InvestorPlace
2 Biotech Stocks You Can Buy and Hold for the Next Decade
November 30, 2023
From Motley Fool
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
November 29, 2023
From Benzinga
Cabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapy
November 28, 2023
From MarketWatch
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later
November 26, 2023
From Motley Fool
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,000 Today
November 21, 2023
Tickers
GILD
From Benzinga
FDA Approves AstraZeneca's Truqap/Faslodex Combo Therapy For Breast Cancer, Competes With Gilead's Drug
November 17, 2023
From Benzinga
Gilead Sciences's Options: A Look at What the Big Money is Thinking
November 15, 2023
Tickers
GILD
From Benzinga
WHO’s new COVID guidelines see fewer patients requiring hospitalization
November 10, 2023
From MarketWatch
A Closer Look at Gilead Sciences's Options Market Dynamics
November 09, 2023
Tickers
GILD
From Benzinga
Take-Two Interactive shares surge on report of new Grand Theft Auto game as Robinhood stock drops on earnings miss
November 08, 2023
From MarketWatch
Gilead Sciences (GILD) Q3 2023 Earnings Call Transcript
November 07, 2023
Tickers
GILD
From Motley Fool
Gilead Sciences Stock Slides After Hours On Q3 Report - Here's Why
November 07, 2023
Tickers
GILD
From Benzinga
Positive News For Gastric Cancers - Gilead/Arcus Biosciences' Combination Cancer Therapy Shows Encouraging Clinical Activity
November 07, 2023
From Benzinga
S&P 500, Nasdaq Set To Break 6-Day Rally Today? Traders Await Fed Cues, Analyst Says Seasonal Rally Has Started With Gusto
November 07, 2023
From Benzinga
A wall of debt rolling over: Here’s what’s scaring Bridgewater’s co-CIO
November 07, 2023
From MarketWatch
S&P 500 futures dip after six-day winning streak
November 07, 2023
From MarketWatch
Disney and other entertainment giants report after upbeat results from peers, but investors are getting harsher on companies that don’t deliver
November 05, 2023
From MarketWatch
Fed Holds Rates Steady, Powell's Cautious Stance Soothes Investors, Labor Market Softens: The Week In The Markets
November 03, 2023
From Benzinga
From Benzinga
3 Pharma Stocks That Are Screaming Buys in October
October 26, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
